Asqav vs Scale AI Evaluation Suite for Agentic AI

“The primitive is clean: sign agent actions with ML-DSA-65, chain the hashes, export the trail — and the API backs that up with a three-call surface (init, create agent, sign action) that doesn't bury you in config before hello-world. The DX bet is complexity-at-the-library-layer, simplicity-at-the-call-site, which is exactly the right call for something this security-sensitive. The only thing I'd flag: multi-agent audit trails are listed as 'in active development,' which means anyone building orchestration topologies today is buying a partial solution — ship it, but go in with that specific gap noted.”

“The primitive here is clear: human-validated, multi-step task scaffolding that gives you ground-truth labels for agentic failure modes — not just 'did it answer correctly' but 'did it take the right sequence of actions without derailing.' That's a real problem. Single-turn evals like MMLU tell you nothing about whether your agent will loop indefinitely on a tool-call error or hallucinate a subtask completion. The DX bet is API-first access to curated test sets, which is the right call — nobody wants to wrangle eval pipelines through a dashboard. My concern is the classic enterprise gate: 'contact sales' before you can touch anything means the first 10 minutes aren't a developer experience at all, they're a sales cycle. If they open a self-serve tier with even a constrained benchmark set, this becomes essential infrastructure. Right now it's a strong idea with a locked door.”

“Direct competitor is 'roll your own append-only log plus a signing library,' and Asqav wins that comparison because ML-DSA-65 with RFC 3161 timestamps is not something most teams will implement correctly on a Friday afternoon. The scenario where this breaks is a large enterprise that needs multi-agent orchestration audit trails right now — that feature gap is real and unshipped. What kills this in 12 months is not a competitor but the OpenAI Agents SDK or LangChain shipping native audit hooks, at which point Asqav either becomes the underlying primitive those hooks call or it becomes redundant — and the MIT license plus the FIPS 204 compliance angle is the only moat that survives that scenario.”

“The direct competitors here are HELM, AgentBench, and whatever evaluation harnesses OpenAI and Anthropic are quietly building into their own platforms — and Scale's actual advantage is the human-labeling infrastructure they've had for a decade. That's not nothing. The scenario where this breaks is any team not already deep in the Scale ecosystem: the enterprise-only pricing means the researchers and indie teams who actually publish eval papers won't use this, which means community validation won't come, which means the benchmarks risk being Scale's proprietary opinion about what 'good' looks like. What kills this in 12 months: model providers ship native agentic eval tooling as a free tier feature, and Scale's moat collapses to 'we have more expensive human raters.' For this to hold, Scale needs to publish the methodology openly and let the community stress-test it — otherwise it's a benchmark designed by the tool's author, which is exactly what I'm tired of.”

“The thesis is specific and falsifiable: regulated industries will require cryptographically verifiable agent action logs before autonomous agents can touch production systems, and that requirement will arrive before most teams have built the infrastructure for it. The dependency that has to hold is that agent autonomy in production continues to expand faster than enterprise security tooling adapts — a trend line that has been running hot since 2024 and shows no sign of reversing. The second-order effect that nobody is talking about: if Asqav becomes the audit standard, it also becomes the replay and forensics standard, which means it accumulates data network effects that the MIT license alone won't protect — whoever hosts the verification infrastructure holds the power.”

“The thesis here is specific and falsifiable: by 2027, enterprises deploying agentic systems will face regulatory and liability pressure to demonstrate measurable, auditable performance on multi-step task completion — and whoever owns the benchmark standard owns the compliance conversation. Scale is betting that evals become a procurement requirement, not just a dev-team nicety. That bet depends on two things going right: enterprise AI deployments actually hitting meaningful failure rates that surface in production (they will), and no open-source consortium standardizing agentic benchmarks before Scale's suite becomes the default reference (less certain). The second-order effect if this wins is significant — Scale becomes the ratings agency for AI agents, which is a power position nobody else currently holds. The trend line is the shift from LLM evals to agent evals, and Scale is early on the productized side of it, even if academia has been discussing it for 18 months. The future state where this is infrastructure: every enterprise AI procurement RFP requires a Scale Evaluation Suite score.”

“The buyer is a security or compliance engineer at a regulated enterprise — financial services, healthcare, federal — and that buyer has budget, which is good. The problem is there's no visible pricing beyond 'free tier,' no enterprise tier, no SLA, no SOC 2, and no indication of what the expand story looks like once teams are hooked on the free plan. MIT-licensed open source with unlimited free usage is a great developer acquisition motion, but it's not a business model — and the moat question is genuinely hard here because the core algorithm is a NIST standard anyone can implement. Ship the product, skip the business until there's a credible answer to 'what do we charge, who do we charge, and what stops AWS from packaging this into CloudWatch next quarter.'”

“The buyer here is the enterprise AI team that already has a Scale contract — this is an expansion product, not a wedge. That's a legitimate land-and-expand play, but the expand story only works if the buyer has both an agentic deployment and a budget line for evaluation infrastructure, which is a narrower Venn diagram than it looks. The moat question is the real issue: Scale's defensibility is human labeling quality and dataset curation, but the moment Google DeepMind or Anthropic decides to open-source a rigorous agentic benchmark suite — which costs them almost nothing to do — Scale's pricing leverage evaporates. 'Contact sales' pricing for an eval product also signals they haven't found the right price point yet, which is a tell. The business survives if Scale can turn benchmark scores into a certification or compliance artifact that enterprises need for insurance or regulation — that's the pricing power scenario. Without that, this is a premium feature for existing customers, not a standalone business.”